LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression

被引:0
|
作者
Yi Sang
Jianjun Tang
Siwei Li
Liping Li
XiaoFeng Tang
Chun Cheng
Yanqin Luo
Xia Qian
Liang-Ming Deng
Lijuan Liu
Xiao-Bin Lv
机构
[1] Nanchang Key Laboratory of Cancer Pathogenesis and Translational Research,Department of Gastroenterology
[2] Center Laboratory,Department of Radiation Oncology
[3] the Third Affiliated Hospital,Department of Medicine
[4] Nanchang University,Department of pharmacy
[5] Cancer Hospital of Jiangxi Province,undefined
[6] the Affiliated Hospital of Guilin Medical University,undefined
[7] GaomingHeshui Hospital,undefined
[8] Cancer Hospital of Jiangxi Province,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It has been reported that lncRNA PANDAR (promoter of CDKN1A antisense DNA damage-activated RNA) is induced as a result of DNA damage, and it regulates the reparation of DNA damage. In this study, we investigated the role of lncRNA PANDAR in the progression of breast cancer and found that PANDAR was up-regulated in breast cancer tissues and cell lines. The knockdown of PANDAR suppresses G1/S transition of breast cancer cells. We demonstrated mechanistically that the regulation of G1/S transition by PANDAR was partly due to the transcriptional modulation of p16INK4A. Moreover, we showed that PANDAR impacted p16INK4A expression by regulating the recruitment Bmi1 to p16INK4A promoter. To our knowledge, this is the first study which showed the functional roles and mechanisms of PANDAR in regulating the progression of breast cancer. The PANDAR/Bmi1/p16INK4A axis could serve as novel targets for breast cancer therapy.
引用
收藏
相关论文
共 50 条
  • [31] Promoter and histone methylation and p16INK4A gene expression in colon cancer
    Yoruker, Ebru Esin
    Mert, Ufuk
    Bugra, Dursun
    Yamaner, Sumer
    Dalay, Nejat
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (05) : 865 - 870
  • [32] Expression and regulation of G1 cell-cycle inhibitors (p16INK4A , p15INK4B, p18 INK4C, p19INK4D ) in human acute myeloid leukemia and normal myeloid cells
    J Schwaller
    Th Pabst
    HP Koeffler
    G Niklaus
    P Loetscher
    MF Fey
    A Tobler
    Leukemia, 1997, 11 : 54 - 63
  • [33] Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms
    Silva, J
    Silva, JM
    Domínguez, G
    García, JM
    Cantos, B
    Rodríguez, R
    Larrondo, FJ
    Provencio, M
    España, P
    Bonilla, F
    JOURNAL OF PATHOLOGY, 2003, 199 (03): : 289 - 297
  • [34] G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression
    Ausserlechner, MJ
    Obexer, P
    Geley, S
    Kofler, R
    LEUKEMIA, 2005, 19 (06) : 1051 - 1057
  • [35] G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression
    M J Ausserlechner
    P Obexer
    S Geley
    R Kofler
    Leukemia, 2005, 19 : 1051 - 1057
  • [36] INK4a gene expression and methylation in primary breast cancer:: Overexpression of p16INK4a messenger RNA is a marker of poor prognosis
    Hui, R
    Macmillan, RD
    Kenny, FS
    Musgrove, EA
    Blamey, RW
    Nicholson, RI
    Robertson, JFR
    Sutherland, RL
    CLINICAL CANCER RESEARCH, 2000, 6 (07) : 2777 - 2787
  • [37] p16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy
    Han, SW
    Ahn, SH
    Park, K
    Bae, BN
    Kim, KH
    Kim, HJ
    Kim, YD
    Kim, HY
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 70 (03) : 205 - 212
  • [38] p16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy
    Sehwan Han
    Sei-Hyun Ahn
    Kyeongmee Park
    Byung-Noe Bae
    Ki Hwan Kim
    Hong-Joo Kim
    Young-Duck Kim
    Hong-Yong Kim
    Breast Cancer Research and Treatment, 2001, 70 : 205 - 212
  • [39] An association between nuclear morphology and immunohistochemical expression of p53 and p16INK4A in lung cancer cells
    Okudela, Koji
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 130 - 136
  • [40] An association between nuclear morphology and immunohistochemical expression of p53 and p16INK4A in lung cancer cells
    Koji Okudela
    Medical Molecular Morphology, 2014, 47 : 130 - 136